BA
AVXL icon

BlackRock Advisors’s Anavex Life Sciences AVXL Stock Holding History

BlackRock Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$81K Buy
20,526
+426
+2% +$1.52K ﹤0.01% 3114
2016
Q3 		$73K Buy
20,100
+6,232
+45% +$26.2K ﹤0.01% 3145
2016
Q2 		$85K Buy
13,868
+10,220
+280% +$49.4K ﹤0.01% 3034
2016
Q1 		$18K Hold
3,648
– – ﹤0.01% 3447
2015
Q4 		$20K Buy
+3,648
New +$26K ﹤0.01% 3490

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BlackRock Advisors's AVXL Position: Q4 2016 in Review

BlackRock Advisors increased its Anavex Life Sciences (AVXL) stake by 2.1% in Q4 2016, buying an estimated $1.52K and bringing the position to 20,526 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

BlackRock Advisors first reported a position in AVXL in Q4 2015 and has held it in 5 quarters since. The position peaked at $85K in Q2 2016. 59 funds tracked by Wall St. Rank hold AVXL as of Q4 2016.

  • BlackRock Advisors held 20,526 shares of Anavex Life Sciences worth $81K as of Q4 2016.
  • BlackRock Advisors bought 426 Anavex Life Sciences shares in Q4 2016, an estimated $1.52K.
  • Anavex Life Sciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3114 holding.
  • BlackRock Advisors first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Anavex Life Sciences position peaked at $85K in Q2 2016.
  • 59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.